Elevated Serum or Plasma Potassium
An artifactually high value can occur with hemolysis of red blood cells (RBCs) during venipuncture, especially if there is prolonged tourniquet use and fist clenching during the drawing of the blood or at any time prior to potassium measurement.
An artifactually high potassium value can also occur when there are greater than 1,000,000 /µL platelets or greater than 100,000/µL white blood cells (WBCs).
Renal failure from any cause, with oliguria, or as chronic nonoliguric renal failure.
Excess potassium supplements, potassium-rich foods, salt substitutes, intravenous (IV) potassium, or infusion of potassium-containing drugs, such as potassium penicillin.
Hypoaldosteronism from Addison's disease or hypofunction of the renin-angiotensin-aldosterone system.
Acute acidosis from diabetic ketoacidosis or from lactic acidosis as found with extensive crush injury, burns, or tissue necrosis.
Ingestion of drugs that inhibit potassium secretion by the kidney.
All of these situations are especially dangerous if the potassium becomes extremely elevated.
Values greater than 7.5 mEq/L are associated with serious cardiac conduction abnormalities.
Commonly Encountered Situations
Hyperkalemia is found frequently in renal failure.
The most common cause of an artifactually elevated potassium is hemolysis of RBCs.
Suggested Additional Lab Testing
Determine whether the serum or plasma showed evidence of hemolysis by a change in color from yellow to pink or red.
Complete blood count (CBC) to assess platelet count and WBC count.
Evidence of renal disease from an elevated creatinine or blood urea nitrogen (BUN), or decreased urine output.
Serum aldosterone to assess for hypoaldosteronism.
Blood gases to evaluate possible acidosis.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Clinical Pain Advisor Articles
- Tools to Address the Opioid Crisis
- Patterns of Non-Medical Prescription Opioid Use in Adolescents
- Pain Acceptance May Reduce Headache-Related Disability in Migraine
- Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You
- Factors Promoting Participation in Self-Management Training Program for Chronic Pain
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Long Wait Times Between Referral and Interdisciplinary Pediatric Chronic Pain Evaluation
- Assessing Headache Management Practices at Community Pharmacies
- Rapid Fentanyl Test Strips Accepted by Young Adult Drug Users
- Moral Hazard vs Morality Approaches in the Opioid Crisis
- Use of Both Aspirin and NSAIDs Associated With Incident Heart Failure Risk
- FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation